1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors
US6677351B2 · kind B2 · utility
4Cited by
21References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 24, 2002 |
| Grant date | Jan 13, 2004 |
| Priority date | — |
| Expiry date | May 24, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds represented by Formula (I): or a pharmaceutically acceptable salt thereof, are phosphodiesterrase 4 inhibitors useful in the treatment of asthma and inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.